Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Quhan Wang Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the China-Japan Friendship Hospital for the treatment of rheumatoid arthritis. It is specifically indicated for patients presenting with the 'kidney deficiency and cold dampness' syndrome. The decoction is designed to tonify the kidneys, expel cold, and remove dampness, which are traditional therapeutic strategies to alleviate joint pain, swelling, and stiffness. As a complex herbal mixture, its mechanism likely involves multi-target anti-inflammatory and immunomodulatory effects, although specific molecular targets for the whole formula are not typically characterized in Western pharmacological terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Quhan Wang Decoction.